The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract
Open Access
- 1 January 1994
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 4 (1) , 52-60
- https://doi.org/10.1046/j.1525-1438.1994.04010052.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Use of serum CA-125 in monitoring patients with uterine sarcoma: A preliminary reportCancer, 1988
- High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterusCancer, 1987
- CA-125:Use as a tumor marker with mixed mesodermal tumors of the female genital tractCancer, 1986
- Patterns of recurrence in malignant mixed müllerian tumor of the uterusCancer, 1986
- Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicinVersus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group)Cancer, 1985
- Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapyCancer, 1983
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983
- Chemotherapy in management of mixed mesodermal tumors of the ovaryGynecologic Oncology, 1980
- Uterine sarcomas.Analysis of failures with special emphasis on the use of adjuvant radiation therapyCancer, 1978
- Uterine sarcomas.Natural history, treatment and prognosisCancer, 1978